Vaccines

Vaccines articles deliver critical analysis and commentary on policy, safety, efficacy, mandates, and their effects on public health, personal liberty, child development, and social life — questioning official narratives and institutional claims.

We cover major issues like COVID-19 vaccine mandates, mRNA risks, vaccine injury reporting, childhood immunization schedules, ACIP decisions, liability protection, informed consent failures, and calls for evidence-based reform and voluntary choice.

Retsef Levi Explains His Vote against Routine RSV Monoclonal Use in Newborns

Retsef Levi Explains His Vote against Routine RSV Monoclonal Use in Newborns

SHARE | PRINT | EMAIL

Levi is no stranger to weighing risk. A professor at MIT with deep experience in data analytics and risk-based decision-making, he had combed through five clinical trials of RSV monoclonals, including clesrovimab and its predecessor, nirsevimab.

Retsef Levi Explains His Vote against Routine RSV Monoclonal Use in Newborns Continue Reading